Long Term Outcome After Use of Vacuum-induced Tamponade for Postpartum Hemorrhage

This study will investigate all women treated with vacuum-induced tamponade (VIT) for PPH at a tertiary center, namely at the University Hospital Zurich (USZ), over a nine-year period (2017-2025). By combining hospital data with follow-up patient questionnaires, it will provide new information on reproductive outcomes and contribute to the evaluation of the long-term safety profile of vacuum-induced tamponade.

Inclusion Criteria: * Women ≥ 18 years of age. * Delivery at the USZ between January 2017 and December 2025. Documented postpartum hemorrhage managed with VIT. * Provision of written informed consent Exclusion Criteria: * Decline of informed consent. * Inability to establish contact (e.g., incorrect address, telephone number not reachable, moved abroad). * Women who are unable to provide informed consent (e.g., due to language barriers without translation support, or cognitive impairment).